WELCOME OFFER — 10% OFF YOUR FIRST ORDER · CODE LAUNCH10 · GET IT BY EMAIL

Ingredient knowledge · Probiotics

Lactobacillus rhamnosus

One of the most widely studied of the lactobacilli — and a lesson in strain specificity

All articles checked for accuracy against the GB NHC Register and all sources have citations with verified links to their relevant studies.

Lactobacillus rhamnosus is one of the most studied live bacterial cultures, largely because of a single well-researched strain. The evidence shows how important strain details and labelling are for interpreting research.

This article explains what Lactobacillus rhamnosus is, why strain specificity matters, how live cultures are measured on labels, where WellsparQ uses the species, and what regulatory bodies say about research claims for live cultures. It flags practical points on form, dietary suitability and safety notes relevant to consumers.

Ingredient Snapshot

Lactobacillus rhamnosus ingredient
What it is
A species of live bacterial culture used in supplements (a lactic acid bacterium).
Where from
Originally Lactobacillus rhamnosus; now Lacticaseibacillus rhamnosus (many strains).
Known for
Widely studied as a live culture, with effects that are strain-specific and research-focused.

Lactobacillus rhamnosus is among the most researched live bacterial cultures in the world, thanks largely to one particular strain — rhamnosus GG — that has been the subject of hundreds of studies. WellsparQ uses L. rhamnosus as a named culture in two blends. It is also a useful example of a wider truth about live cultures: what is true of one strain is not necessarily true of another, even within the same species.

What the name — and the new name — tell you

Lactobacillus rhamnosus was long placed in the Lactobacillus genus, but the 2020 reorganisation of that genus moved it into a new one: it is now correctly called Lacticaseibacillus rhamnosus ¹. The species name is unchanged, and the familiar "Lactobacillus rhamnosus" label persists in everyday use. The WellsparQ factsheet describes it plainly as "one of the most widely used Lactobacillus species" and "first of four Lactobacillus strains named on the label".

The best-known strain, rhamnosus GG (often shortened to LGG), is a benchmark in the research literature — a reminder that the meaningful unit is the strain, identified by an alphanumeric code, not just the species ².

How live cultures are counted

Live cultures are measured in colony-forming units (CFU), an estimate of viable cells able to grow. Only living cells act as a culture, and cells die over time, so the informative figure is the CFU count at the end of shelf life; labels are otherwise only obliged to give the total microorganism weight, which includes dead cells ².

WellsparQ productDeclared L. rhamnosusContext
BioFlora DailyLactobacillus rhamnosus (named strain)One of the named daily cultures
GutBiome 20Lactobacillus rhamnosus (named strain)"First of four Lactobacillus strains named on the label"

Source: WellsparQ Supplements Database. In both products rhamnosus is a named component of a multi-strain culture, disclosed rather than hidden.

The research, framed as research — and why strain matters

The scientific category for live cultures studied for a health effect is probiotic, defined by the International Scientific Association for Probiotics and Prebiotics as "live microorganisms that, when administered in adequate amounts, confer a health benefit on the host" ²³. That is a description of a research field, not a WellsparQ claim.

L. rhamnosus GG is one of the most trialled strains, and its results illustrate how carefully evidence must be read:

Research example (LGG)Reported outcome
Large US trial, acute gastroenteritis in children (NEJM 2018) ⁴LGG did not shorten illness versus placebo
Meta-analysis, antibiotic-associated diarrhoea (2015) ⁵Signal of benefit, but authors urged caution on strain/dose
Meta-analysis, prevention of eczema in children (2018) ⁶LGG did not reduce eczema risk
Weight-management RCT (2014) ⁷No overall weight effect; a difference only in a female subgroup

The picture is mixed, strain-specific and often null — which is exactly why reputable bodies stress that evidence for one strain, dose or condition cannot be transferred to another ². All of the above is reported here as sourced research with its limitations, not as anything WellsparQ asserts about its products.

Forms and suitability

Supplement L. rhamnosus is grown by fermentation and freeze-dried into a stable powder. As a bacterial culture it generally suits vegetarian and vegan diets; where grown on a dairy-derived medium, that is an allergen point to check on the finished label.

Safety

L. rhamnosus has a strong safety record in general use. Live cultures are well tolerated by most people, sometimes with brief bloating or wind at first. There are rare reports of Lactobacillus bloodstream infection in seriously ill or profoundly immunocompromised individuals ², so such people — and anyone critically ill or caring for very premature infants — should seek medical advice before using live-culture supplements. Anyone pregnant, breastfeeding or on medication should check with a GP or pharmacist. Take as directed.

References

  1. Zheng J, et al. A taxonomic note on the genus Lactobacillus... Int J Syst Evol Microbiol 2020;70:2782–2858 — L. rhamnosus reclassified as Lacticaseibacillus rhamnosus. PMID 32293557. ↩ Back to text
  2. National Institutes of Health, Office of Dietary Supplements. Probiotics: Fact Sheet for Health Professionals — CFU labelling, strain specificity, safety. ods.od.nih.gov (accessed 2026). ↩ Back to text
  3. Hill C, et al. ISAPP consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014;11(8):506–514. PMID 24912386. ↩ Back to text
  4. Schnadower D, et al. Lactobacillus rhamnosus GG versus Placebo for Acute Gastroenteritis in Children. N Engl J Med 2018;379:2002–2014. PMID 30462938. ↩ Back to text
  5. Szajewska H, Kołodziej M. Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults. Aliment Pharmacol Ther 2015;42:1149–1157. PMID 26365389. ↩ Back to text
  6. Szajewska H, Horvath A. Lactobacillus rhamnosus GG in the primary prevention of eczema in children: a systematic review and meta-analysis. Nutrients 2018;10:1319. PMID 30231505. ↩ Back to text
  7. Sanchez M, et al. Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women. Br J Nutr 2014;111:1507–1519. PMID 24299712. ↩ Back to text
  8. GB/EU Register of nutrition and health claims — probiotic/botanical general-function claims on hold; "probiotic" not permitted as a claim. ec.europa.eu food-feed-portal.
General information only — not medical advice. Food supplements should not be used as a substitute for a varied diet and a healthy lifestyle. Do not exceed the stated recommended daily dose. Keep out of reach of young children. If you are pregnant, breastfeeding, or taking medication, speak to your GP or pharmacist before starting a new supplement.
Shopping Basket